CENTRAL RETINAL VEIN OCCLUSION IN YOUNG PATIENTS: Clinical Characteristics and Prognostic Factors

Retina. 2021 Mar 1;41(3):630-637. doi: 10.1097/IAE.0000000000002872.

Abstract

Purpose: To investigate the clinical characteristics and prognostic factors of young patients with central retinal vein occlusion (CRVO).

Methods: This retrospective cohort study involved treatment-naïve patients with CRVO. Medical records regarding basic demographics, predisposing factors, ocular characteristics, and treatments were reviewed and compared according to age at CRVO onset.

Results: We enrolled 263 patients, of whom 69 were younger patients. Younger patients had higher prevalence of nontraditional risk factors including physical or psychological stress (P = 0.032), hematologic abnormalities (P = 0.003), and better visual acuity at baseline and last visit (all P < 0.001) and were unlikely to undergo intravitreal injections (47.8 vs. 68.6%, P < 0.001) during follow-up. Younger patients had higher prevalence of paracentral acute middle maculopathy (28.1 vs. 4.7%, P < 0.001). Older age (odds ratio = 1.165, P = 0.028), male sex (odds ratio = 7.074, P = 0.034), coexisting renal disease (odds ratio = 7.845, P = 0.050), and poor baseline visual acuity (odds ratio = 16.069, P = 0.002) were significant risk factors for poor visual outcomes in young CRVO patients.

Conclusion: Younger CRVO patients had a milder clinical course with fewer treatments and were more likely to have nontraditional risk factors than older patients.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Angiogenesis Inhibitors / administration & dosage
  • Bevacizumab / administration & dosage*
  • Female
  • Follow-Up Studies
  • Glucocorticoids / administration & dosage
  • Humans
  • Intravitreal Injections
  • Male
  • Middle Aged
  • Prognosis
  • Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
  • Republic of Korea / epidemiology
  • Retinal Vein Occlusion / diagnosis*
  • Retinal Vein Occlusion / drug therapy
  • Retinal Vein Occlusion / epidemiology
  • Retinal Vessels / diagnostic imaging*
  • Retrospective Studies
  • Risk Assessment / methods*
  • Tomography, Optical Coherence / methods*
  • Treatment Outcome
  • Triamcinolone Acetonide / administration & dosage*
  • Visual Acuity*
  • Young Adult

Substances

  • Angiogenesis Inhibitors
  • Glucocorticoids
  • Bevacizumab
  • Receptors, Vascular Endothelial Growth Factor
  • Triamcinolone Acetonide